Most Active Stocks in Pre-Market on October 20, 2025: REPL, RANI, TSLL, SQQQ, BITF, NUAI, ACHR, NIO, BBAI, IONQ, LAC, CLF
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 20 2025
0mins
Should l Buy CL?
Source: NASDAQ.COM
NASDAQ 100 Pre-Market Performance: The NASDAQ 100 Pre-Market Indicator is up 125.6 points to 24,943.55, with a total pre-market volume of 372,164,591 shares traded.
Most Active Stocks: Replimune Group, Inc. (REPL) leads with a significant increase of 4.09 to $8.59, while other notable active stocks include Rani Therapeutics Holdings, Inc. (RANI) and Direxion Daily TSLA Bull 2X Shares (TSLL), both showing positive movements.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CL
Wall Street analysts forecast CL stock price to fall
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 87.950
Low
77.00
Averages
87.79
High
95.00
Current: 87.950
Low
77.00
Averages
87.79
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Update Release: On March 13, 2026, the New York Stock Exchange (NYSE) issued a daily pre-market advisory aimed at providing investors with insights before the market opens, assisting them in making more informed trading decisions.
- Opening Ceremony: ServiceNow (NYSE:NOW) CEO Bill McDermott conducted the opening ceremony for the US markets, marking the start of the trading day and highlighting the company's significant position in the market.
- Closing Activities: At the closing bell, EltaMD Skin Care, a brand under Colgate-Palmolive, celebrated the 3rd Annual National Dermatologist Day, emphasizing the brand's influence in the skincare industry and recognition among professionals.
- Celebrity Event Recap: The NYSE also recapped the visit of Olympic champions Madison Chock and Evan Bates, showcasing the exchange's connection with the sports community and enhancing its public image.
See More
- Market Update: The New York Stock Exchange (NYSE) issued a daily pre-market advisory on March 13, 2026, providing market insights aimed at helping investors make informed decisions before trading begins.
- Oil Price Impact: ICE Brent Crude oil prices remain above $100 per barrel, reflecting the potential market impact of the conflict in Iran, which poses risks of weekly losses for U.S. stock market indices.
- Sports and Finance Intersection: U.S. figure skaters Madison Chock and Evan Bates were interviewed at the NYSE, celebrating their gold and silver medals at the Milan Cortina Winter Games, showcasing the intersection of sports and financial markets.
- Corporate Highlights: ServiceNow CEO Bill McDermott opened the U.S. markets at the NYSE, marking the start of trading, while EltaMD Skin Care brand celebrated National Dermatologist Day, enhancing brand visibility.
See More
- Dividend Increase: Colgate-Palmolive has declared a quarterly dividend of $0.53 per share, marking a 1.9% increase from the previous $0.52, demonstrating the company's ongoing commitment to stable cash flow and shareholder returns.
- Yield Performance: The forward yield of this dividend stands at 2.41%, which not only attracts income-seeking investors but also reflects the company's financial health in the current market environment.
- Payment Schedule: The dividend is payable on May 15, with a record date of April 20 and an ex-dividend date also set for April 20, ensuring shareholders receive timely returns and bolstering investor confidence.
- Sales Growth Target: Colgate-Palmolive has outlined an organic sales growth target of 1% to 4% for 2026, indicating a positive outlook and strategic planning despite facing volatility in category trends.
See More
- Emergence of Cloud Computing: The cloud began to gain prominence in 2011, marking a significant shift in the technology landscape.
- Marc Andreessen's Insight: Venture capitalist Marc Andreessen highlighted the trend by stating that "software is eating the world," indicating a move away from hardware-centric models.
- Commoditization of Hardware: As software became more dominant, hardware started to be viewed as a commodity, impacting IT budgets.
- Shift in IT Budgets: Business software increasingly took precedence in IT spending, reflecting the changing priorities in technology investments.
See More
- Dividend Increase: Colgate-Palmolive announced an increase in its quarterly cash dividend from $0.52 to $0.53 per share, effective in the second quarter of 2026, demonstrating the company's ongoing profitability and commitment to shareholder returns.
- Annual Dividend Comparison: The new annualized dividend rate stands at $2.12 per share, up from $2.08 previously, reflecting the company's positive performance in maintaining stable cash flow and profit growth.
- New Board Member: Christopher Boerner, Ph.D., CEO of Bristol-Myers Squibb, will join Colgate-Palmolive's Board on March 15, 2026, bringing extensive global business leadership experience, particularly in the pharmaceutical and healthcare sectors, which could enhance the company's strategic direction.
- Board Changes: Steven A. Cahillane announced he will not seek reelection, a change that may impact the company's strategic direction and governance structure, with Chairman Noel Wallace expressing gratitude and anticipation for the contributions of the new board member.
See More

- Election Announcement: Colgate-Palmolive has announced the election of Christopher Boerner to the Board of Directors.
- Effective Date: The appointment will take effect on March 15, 2026.
See More








